Literature DB >> 28404583

Acute hypoxia activates neuroendocrine, but not presympathetic, neurons in the paraventricular nucleus of the hypothalamus: differential role of nitric oxide.

K Max Coldren1, De-Pei Li2, David D Kline1,3,4, Eileen M Hasser1,3,5, Cheryl M Heesch6,3,4.   

Abstract

Hypoxia results in decreased arterial Po2, arterial chemoreflex activation, and compensatory increases in breathing, sympathetic outflow, and neuroendocrine secretions, including increased secretion of AVP, corticotropin-releasing hormone (CRH), adrenocorticotropin hormone (ACTH), and corticosterone. In addition to a brain stem pathway, including the nucleus tractus solitarius (nTS) and the rostral ventrolateral medulla (RVLM), medullary pathways to the paraventricular nucleus of the hypothalamus (PVN) contribute to chemoreflex responses. Experiments evaluated activation of specific cell phenotypes within the PVN following an acute hypoxic stimulus (AH; 2 h, 10% O2) in conscious rats. Retrograde tracers (from spinal cord and RVLM) labeled presympathetic (PreS) neurons, and immunohistochemistry identified AVP- and CRH-immunoreactive (IR) cells. c-Fos-IR was an index of neuronal activation. Hypoxia activated AVP-IR (~6%) and CRH-IR (~15%) cells, but not PreS cells in the PVN, suggesting that sympathoexcitation during moderate AH is mediated mainly by a pathway that does not include PreS neurons in the PVN. Approximately 14 to 17% of all PVN cell phenotypes examined expressed neuronal nitric oxide synthase (nNOS-IR). AH activated only nNOS-negative AVP-IR neurons. In contrast ~23% of activated CRH-IR neurons in the PVN contained nNOS. In the median eminence, CRH-IR terminals were closely opposed to tanycyte processes and end-feet (vimentin-IR) in the external zone, where vascular NO participates in tanycyte retraction to facilitate neuropeptide secretion into the pituitary portal circulation. Results are consistent with an inhibitory role of NO on AVP and PreS neurons in the PVN and an excitatory role of NO on CRH secretion in the PVN and median eminence.
Copyright © 2017 the American Physiological Society.

Entities:  

Keywords:  AVP; CRH; corticotropin-releasing hormone; median eminence; nitric oxide; vasopressin

Mesh:

Substances:

Year:  2017        PMID: 28404583      PMCID: PMC6148210          DOI: 10.1152/ajpregu.00543.2016

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  73 in total

1.  Hypoxia activates nucleus tractus solitarii neurons projecting to the paraventricular nucleus of the hypothalamus.

Authors:  T Luise King; Cheryl M Heesch; Catharine G Clark; David D Kline; Eileen M Hasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-07       Impact factor: 3.619

2.  Sensory afferent and hypoxia-mediated activation of nucleus tractus solitarius neurons that project to the rostral ventrolateral medulla.

Authors:  D D Kline; T L King; J R Austgen; C M Heesch; E M Hasser
Journal:  Neuroscience       Date:  2010-02-12       Impact factor: 3.590

3.  Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamus of the intact rat.

Authors:  S Lee; C K Kim; C Rivier
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

4.  Differential role of the paraventricular nucleus of the hypothalamus in modulating the sympathoexcitatory component of peripheral and central chemoreflexes.

Authors:  Maram K Reddy; Kaushik P Patel; Harold D Schultz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-05-26       Impact factor: 3.619

5.  Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain.

Authors:  Amandine Mullier; Sebastien G Bouret; Vincent Prevot; Bénédicte Dehouck
Journal:  J Comp Neurol       Date:  2010-04-01       Impact factor: 3.215

6.  Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties.

Authors:  J Wood; J Garthwaite
Journal:  Neuropharmacology       Date:  1994-11       Impact factor: 5.250

7.  Hypophysiotropic thyrotropin-releasing hormone and corticotropin-releasing hormone neurons of the rat contain vesicular glutamate transporter-2.

Authors:  Erik Hrabovszky; Gábor Wittmann; Gergely F Turi; Zsolt Liposits; Csaba Fekete
Journal:  Endocrinology       Date:  2004-10-14       Impact factor: 4.736

8.  Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA.

Authors:  K Zhang; K P Patel
Journal:  Am J Physiol       Date:  1998-09

Review 9.  Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms.

Authors:  Y-F Li; K P Patel
Journal:  Acta Physiol Scand       Date:  2003-01

10.  Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat.

Authors:  R K Chan; P E Sawchenko
Journal:  J Comp Neurol       Date:  1994-10-15       Impact factor: 3.215

View more
  17 in total

Review 1.  Impaired Hypothalamic Regulation of Sympathetic Outflow in Primary Hypertension.

Authors:  Jing-Jing Zhou; Hui-Jie Ma; Jian-Ying Shao; Hui-Lin Pan; De-Pei Li
Journal:  Neurosci Bull       Date:  2018-12-01       Impact factor: 5.203

Review 2.  Regulation of sympathetic vasomotor activity by the hypothalamic paraventricular nucleus in normotensive and hypertensive states.

Authors:  Roger A Dampney; Lisete C Michelini; De-Pei Li; Hui-Lin Pan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-10       Impact factor: 4.733

3.  Combined hypoxia and hypercapnia, but not hypoxia alone, suppresses neurotransmission from orexin to hypothalamic paraventricular spinally-projecting neurons in weanling rats.

Authors:  Olga Dergacheva; David Mendelowitz
Journal:  Brain Res       Date:  2017-11-21       Impact factor: 3.252

4.  Hydrogen peroxide inhibits neurons in the paraventricular nucleus of the hypothalamus via potassium channel activation.

Authors:  Heather A Dantzler; Michael P Matott; Diana Martinez; David D Kline
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-01       Impact factor: 3.619

5.  Hypothalamic PVN contributes to acute intermittent hypoxia-induced sympathetic but not phrenic long-term facilitation.

Authors:  Megan B Blackburn; Mary Ann Andrade; Glenn M Toney
Journal:  J Appl Physiol (1985)       Date:  2017-12-21

6.  Enhanced Hypothalamic NMDA Receptor Activity Contributes to Hyperactivity of HPA Axis in Chronic Stress in Male Rats.

Authors:  Jing-Jing Zhou; Yonggang Gao; Xiangjian Zhang; Therese A Kosten; De-Pei Li
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

7.  CRHR2 (Corticotropin-Releasing Hormone Receptor 2) in the Nucleus of the Solitary Tract Contributes to Intermittent Hypoxia-Induced Hypertension.

Authors:  Lei A Wang; Dianna H Nguyen; Steve W Mifflin
Journal:  Hypertension       Date:  2018-10       Impact factor: 10.190

8.  Activation of alpha-1 adrenergic receptors increases cytosolic calcium in neurones of the paraventricular nucleus of the hypothalamus.

Authors:  William J Milanick; Luis Polo-Parada; Heather A Dantzler; David D Kline
Journal:  J Neuroendocrinol       Date:  2019-10-13       Impact factor: 3.627

9.  The PVN enhances cardiorespiratory responses to acute hypoxia via input to the nTS.

Authors:  Brian C Ruyle; Diana Martinez; Cheryl M Heesch; David D Kline; Eileen M Hasser
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-11       Impact factor: 3.619

10.  Transcription factor ΔFosB acts within the nucleus of the solitary tract to increase mean arterial pressure during exposures to intermittent hypoxia.

Authors:  Qiong Wu; J Thomas Cunningham; Steve Mifflin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-03       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.